NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES
BURCON FILES PRELIMINARY SHORT FORM PROSPECTUS
Vancouver, British Columbia, May 28, 2009 — Burcon NutraScience Corporation (TSXV – BU) (“Burcon” or the “Corporation”) announced today that it has filed a preliminary short form prospectus with the securities regulatory authorities in the Provinces of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick and Nova Scotia in connection with a best efforts offering of common shares of the Corporation (the “Offering”). The net proceeds of
the Offering shall be used for continued research and development of the soy protein isolate extraction and purification technology (CLARISOY™), further refining of the canola protein isolate extraction and purification technology (Puratein® and Supertein™), filing new patent applications and expanding the Company’s intellectual property portfolio, and for general
working capital purposes.
The Offering will be led by Paradigm Capital Inc. with a syndicate comprised of BMO Capital Markets and Haywood Securities Inc. Final pricing and determination of the number of common shares to be sold pursuant to the Offering will occur immediately prior to the filing of the (final) short form prospectus in respect of the Offering.
The Offering is subject to regulatory approval including approval of the TSX Venture Exchange.
This press release is not an offer to sell or the solicitation of an offer to buy the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account
or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements.
About Burcon NutraScience
Burcon is a leader in nutrition, health and wellness in the field of functional, renewable plant proteins. Since 1999, Burcon has developed a portfolio of composition, application, and process patents originating from our core protein extraction and purification technology. We are developing the world's first commercial canola proteins, Puratein® and Supertein™ with unique functional and nutritional attributes, and CLARISOY™ , a revolutionary soy protein isolate which is 100% soluble and completely transparent in acidic solutions. Our team of highly specialized scientists and engineers work from our own research facility to develop and optimize environmentally sound technologies. To-date, our patent portfolio consists of 84 issued patents in various countries, including 8 issued U.S. patents, and well in excess of 200 pending patent applications, 55 of which are U.S. patent applications.
ON BEHALF OF THE BOARD OF DIRECTORS
“Johann F. Tergesen”
Johann F. Tergesen
President and Chief Operating Officer
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release contains forward-looking statements that involve risks and uncertainties. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact. Our expectations regarding the prospect for future success depend upon our ability to develop and sell products, which we do not produce today and cannot be sold without further research and development. When used in this press release, the words “goal”, “capital raising”, “intend”, “believes” and “potential” and similar expressions, generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties. In light of the many risks and uncertainties surrounding the development of a source of protein from canola meal, you should understand that we cannot assure you that the forward looking statements contained in this press release will be realized.
For more information, please contact:
Jade Cheng, Chief Financial Officer
Burcon NutraScience Corporation
(604) 733-0896 / (888) 408-7960 toll-free
Sven Olsson, Investor Relations Europe
AXINO AG, Königstraße 26, 70173 Stuttgart, Germany
Tel. +49-711-25 35 92-30 / Fax +49-711-25 35 92-33
To view this News Release in PDF, click here.